|
Volume 272, Number 45, Issue of November 7, 1997
pp. 28308-28314
Uncoupling of Calcium Mobilization and Entry Pathways in
Endothelin-stimulated Pituitary Lactotrophs*
(Received for publication, August 6, 1997, and in revised form, September 9, 1997)
Agnieszka
Lachowicz
,
Fredrick
Van Goor
,
Ann C.
Katzur
,
Gabrielle
Bonhomme
and
Stanko S.
Stojilkovic
From the Endocrinology and Reproduction Research Branch, NICHD,
National Institutes of Health, Bethesda, Maryland 20892
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
In cells expressing
Ca2+-mobilizing receptors, InsP3-induced
Ca2+ release from intracellular stores is commonly
associated with extracellular Ca2+ influx. Operation of
these two Ca2+ signaling pathways mediates
thyrotropin-releasing hormone (TRH) and angiotensin II (AII)-induced
prolactin secretion from rat pituitary lactotrophs. After an initial
hyperpolarization induced by Ca2+ mobilization from the
endoplasmic reticulum (ER), these agonists generated an increase in the
steady-state firing of action potentials, further facilitating
extracellular Ca2+ influx and prolactin release. Like TRH
and AII, endothelin-1 (ET-1) also induced a rapid release of
Ca2+ from the ER and a concomitant spike prolactin
secretion during the first 3-5 min of stimulation. However, unlike TRH
and AII actions, Ca2+ mobilization was not coupled to
Ca2+ influx during sustained ET-1 stimulation, as ET-1
induced a long-lasting abolition of action potential firing. This lead
to a depletion of the ER Ca2+ pool, a prolonged decrease in
[Ca2+]i, and sustained inhibition of prolactin
release. ET-1-induced inhibition and TRH/AII-induced stimulation of
Ca2+ influx and hormone secretion were reduced in the
presence of the L-type Ca2+ channel blocker, nifedipine.
Basal [Ca2+]i and prolactin release were also
reduced in the presence of nifedipine. Furthermore, TRH-induced
Ca2+ influx and secretion were abolished by ET-1, as TRH
was unable to reactivate Ca2+ influx and prolactin release
in ET-1-stimulated cells. Depolarization of the cells during sustained
inhibitory action of ET-1, however, increased
[Ca2+]i and prolactin release. These results
indicate that L-type Ca2+ channel represents a common
Ca2+ influx pathway that controls basal
[Ca2+]i and secretion and is regulated by TRH/AII
and ET-1 in an opposite manner. Thus, the receptor-mediated uncoupling of Ca2+ entry from Ca2+ mobilization provides
an effective control mechanism in terminating the stimulatory action of
ET-1. Moreover, it makes electrically active lactotrophs quiescent and
unresponsive to other calcium-mobilizing agonists.
INTRODUCTION
Typically, in anterior pituitary cells operated by
calcium-mobilizing agonists, release of Ca2+ from
intracellular Ca2+ stores is associated with extracellular
Ca2+ influx. The coordinate actions of these two pathways
provide long-lasting Ca2+ signals and secretion during
sustained agonist stimulation (1). Endothelins
(ETs)1 are common
calcium-mobilizing agonists for secretory pituitary cells and operate
through ETA receptors (2, 3) coupled to phospholipase C-
(4) but not phospholipase D-dependent signaling pathways
(5). In lactotrophs, the ET-1-induced release of Ca2+ from
intracellular pools is associated with a rapid and transient increase
in prolactin secretion (6, 7) followed by a prolonged inhibition to
below basal levels (8). This bidirectional effect of a
calcium-mobilizing agonist on secretion is uncommon among cells
expressing phospholipase C-coupled receptors and is unique for cells
expressing ETA receptors. The mechanism underlying the paradoxical action of ETs on hormone secretion is still unknown. It is
unlikely that a rapid desensitization of ETA receptors
could explain the inhibition of secretion observed in lactotrophs.
Therefore, as the sustained phase in hormone secretion is affected in
ET-1-stimulated lactotrophs, we addressed the alternate hypothesis that
Ca2+ influx is uncoupled from Ca2+ mobilization
in ET-1-stimulated lactotrophs, leading to depletion of the ER calcium
pool and inhibition of hormone secretion.
To test this hypothesis, rat pituitary lactotrophs were employed. These
cells exhibit spontaneous, extracellular
Ca2+-dependent action potential (AP) activity
(9), which is tightly coupled to basal prolactin secretion (10). In
addition to ETA receptors, lactotrophs express
thyrotropin-releasing hormone (TRH) receptors (11), the
calcium-mobilizing actions of which have been well characterized (12).
Angiotensin II (AII) also stimulates prolactin release, presumably
through activation of AT1B receptors (13). Two calcium
entry pathways are proposed to operate in lactotrophs: voltage-gated
(VGCC) and store-operated (SOCC) calcium channels (12). Our results
indicate that Ca2+ influx through VGCC rather than through
SOCC is essential for the sustained secretagogue actions of TRH and
AII. In contrast to these agonists, ET-1 inhibits voltage-gated
Ca2+ influx, leading to a depletion of the ER calcium pool,
a decrease in [Ca2+]i, and prolonged inhibition
of prolactin release.
MATERIALS AND METHODS
Chemicals
GnRH, TRH, AII, and ET-1 were obtained from
Peninsula Laboratories (Belmont, CA). Fura 2-AM was purchased from
Molecular Probes (Eugene, OR). All other chemicals were purchased from
Sigma.
Cell Culture and Hormone Secretion
Anterior pituitary
glands from adult female Sprague-Dawley rats obtained from Charles
River Inc. (Wilmington, MA) were dispersed into single cells by a
trypsin/DNase treatment procedure (14). All experiments were performed
in either mixed pituitary cell populations or purified lactotroph
populations. Cell purification of dispersed pituitary cells was done by
sedimentation on a ficol gradient as described previously (15). For
cell column perifusion, 2 × 107 cells were incubated
with preswollen cytodex-1 beads in 60-mm culture dishes for 2 days. The
cells were then loaded into temperature-controlled chambers and
perifused at 37 °C with Hanks' M199 containing 20 mM
HEPES and 0.1% bovine serum albumin for 60 min at a flow rate of 0.6 or 1.0 ml/min, after which a stable basal secretion rate was
established. During the test period, 3-s or 1-min fractions were
collected, and the perifusate was subsequently stored at 20 °C.
Prolactin content in each fraction was determined by radioimmunoassay using the reagents and standards provided by the National Pituitary Agency (Baltimore).
Calcium Measurements
Cells were plated on coverslips coated
with poly-L-lysine and cultured in medium 199 containing
Earle's salts, sodium bicarbonate, horse serum, and antibiotics for
24-48 h. For cytosolic Ca2+ measurements, the cells were
incubated for 60 min at 37 °C with 2 µM fura 2-AM in
phenol red-free medium 199 containing Hanks' salts, 20 mM
sodium bicarbonate, and 20 mM HEPES. Coverslips with cells
were washed with phenol red-free physiological buffer and mounted on
the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen,
Germany) attached to an Attofluor digital fluorescence microscopy
system (Atto Instruments, Rockville, MD). Cells were examined under a
40× oil immersion objective during exposure to alternating 340- and
380-nm light beams, and the intensity of light emission at 505 nm was
measured. [Ca2+]i is expressed as the ratio of
340 nM/380 nM (F(340)/F(380)).
Electrophysiological Recording
Membrane potential
(Vm) was measured using the perforated patch-clamp
recording technique (16). Before recording, the culture medium was
replaced with a solution containing (in mM) 140 NaCl, 4 KCl, 2.6 CaCl2, 1 MgCl2, 10 HEPES, and 5 glucose (pH adjusted to 7.36 using NaOH). Patch-clamp pipettes were
fabricated from borosilicate glass (type 7740; World Precision
Instruments, Sarasota, FL) using a horizontal micropipette puller
(model P-87; Sutter Instrument Co., Novato, CA) and heat polished to a
final tip resistance of 2-4 M . The composition of the pipette
solutions was (in mM) 70 KCl, 70 K+-aspartate,
1 MgCl2, 10 HEPES (pH adjusted to 7.2 with KOH).
Amphotericin B (Sigma) was added from a stock solution to obtain a
final concentration of 240 µg/ml. The signals were recorded under the
current-clamp mode using an Axopatch 200B patch-clamp amplifier (Axon
Instruments, Foster City, CA). A 3 M KCl-agar bridge was
placed between the bathing solution and the reference electrode.
Records were filtered at 2 kHz using a low pass bessel filter and
digitized using the software package AxoScope 1.0 in conjunction with a
Digidata 1200A A/D converter (Axon Instruments). All reported membrane
potentials were corrected for a liquid junction potential error of 10 mV calculated using the JPCalc program (17). For calcium imaging and
electrophysiological experiments, all drugs were either applied directly to the bath or perifused at a rate of 2 ml/min, during which
complete solution exchange around the cells occurred within 20-30
s.
RESULTS
In cell column perifusion experiments, continuous stimulation with
100 nM ET-1 induced a rapid and transient increase in
prolactin release (Fig. 1A),
the amplitude of which was determined by agonist concentration (data
not shown). The spike phase was followed by a sustained inhibitory
phase, during which prolactin secretion was significantly below that
observed in controls (Fig. 1A). Activation of TRH and AII
receptors also induced a rapid spike-like pattern of prolactin release;
however, unlike the ET-1 response, the spike was followed by a
sustained plateau phase, in which prolactin secretion remained elevated
above basal levels (Fig. 1B). To determine if the pattern of
[Ca2+]i signaling in response to ET-1, TRH, and
AII mirrors that of secretion, we monitored changes in
[Ca2+]i in single rat lactotrophs using the
membrane-permeant Ca2+ indicator dye, fura 2-AM.
Endothelin-1 induced a rapid rise in [Ca2+]i,
followed by a decrease to below basal levels (Fig. 1C). In
contrast, in TRH- and AII-stimulated lactotrophs, the spike phase of
the [Ca2+]i response was followed by sustained
plateau phase (Fig. 1D).
Fig. 1.
Effects of the calcium-mobilizing agonists
ET-1, TRH, and AII on cytosolic calcium concentrations
([Ca2+]i) in single cells
(C and D) and prolactin (PRL)
release from perifused pituitary cells (A and
B). Arrows indicate the times of agonist
applications. Cells were continuously exposed to agonists from the
moment of application to the end of the experiments.
[View Larger Version of this Image (22K GIF file)]
During perifusion of dispersed pituitary cells at a flow rate of 0.6 ml/min with the collection of 1-min fractions, the stimulatory action
of ET-1 lasted for 3-5 min (Fig. 1A). This is in contrast to the [Ca2+]i, which was elevated above basal
levels for about 1-2 min. To better compare the hormone release
response to ET-1 with that of changes in [Ca2+]i,
the effects of ET-1 were further examined using a rapid perifusion
system, in which the flow rate was adjusted to 1.0 ml/min, and 3-s
fractions were collected. The secretory profile was then compared with
an averaged [Ca2+]i response from lactotrophs
stimulated with 100 nM ET-1. Under these conditions, the
hormone release profile mirrored that of the changes in
[Ca2+]i (Fig. 2).
This further supports the view that the pattern of ET-1-induced changes
in [Ca2+]i determines that of prolactin
release.
Fig. 2.
Comparison of the profiles of
[Ca2+]i response and prolactin
(PRL) release in pituitary lactotrophs. Calcium
tracing represents the computer-derived means of data from 47 lactotrophs. Fractions for prolactin release were collected every
3 s at a flow rate of 1 ml/min.
[View Larger Version of this Image (17K GIF file)]
Another difference in TRH/AII- versus ET-1-stimulated cells
was related to the pattern of recovery after the termination of stimuli. The removal of TRH and AII was followed by a return in the
[Ca2+]i (Fig. 3A) and secretory
responses (data not shown) to basal levels within 1-2
min. In contrast, at least 30 min was required for the recovery of basal [Ca2+]i (Fig.
3B) and prolactin secretion (Fig. 3C) following ET-1 treatment. These data indicate that TRH and AII operate in a
manner typical for Ca2+-mobilizing agonists, inducing
biphasic effects, which consist of an early spike and
sustained plateau responses. Additionally, the stimulatory actions are
terminated immediately upon their removal. In contrast, ET-1 exerts
bidirectional effects on [Ca2+]i and
secretion. This includes an early stimulation followed by a sustained
inhibition, the latter being present for a prolonged period upon
removal of the agonist.
Fig. 3.
Patterns of
[Ca2+]i and secretory responses
in TRH- and ET-1-stimulated lactotrophs. A and B, effects of addition and removal of TRH and ET-1 on
[Ca2+]i in single lactotrophs. In B,
the rate of sampling was 60/min during the first 5 min, followed by
3/min. C, stimulation, inhibition, and recovery of secretion
in cells perifused at a flow rate of 0.6 ml/min, with a fraction
collection of 1 per min. Bar indicates duration of agonist
application.
[View Larger Version of this Image (15K GIF file)]
Typical bidirectional effects of ET-1 on [Ca2+]i
and secretion were regularly observed in single lactotrophs bathed in
Ca2+-containing medium (Figs. 1, 2, 3). In cells bathed in
Ca2+-deficient medium, ET-1 induced a monophasic increase
in prolactin secretion and [Ca2+]i (Fig.
4, A and B).
Thyrotropin-releasing hormone also induced a monophasic increase in
[Ca2+]i (Fig. 4C). Readdition of
extracellular Ca2+ in TRH- but not ET-1-stimulated cells
lead to an immediate increase in [Ca2+]i.
Depletion of extracellular Ca2+ consistently reduced
[Ca2+]i and prolactin secretion, indicating that
Ca2+ entry is coupled to basal
[Ca2+]i and prolactin secretion in lactotrophs
(Fig. 4, A-C). Thus, it is likely that a common
Ca2+ influx pathway controls basal
[Ca2+]i and secretion and is facilitated by
TRH/AII and inhibited by ET-1.
Fig. 4.
Effects of extracellular Ca2+
depletion on basal and agonist-induced Ca2+ responses and
prolactin release in perifused pituitary cells. A,
comparison of the effects of ET-1 on prolactin release in cells
perifused with Ca2+-deficient and
Ca2+-containing media. B and C,
typical profiles of [Ca2+]i in cells stimulated
with 5-min pulses of TRH or ET-1 after removal of extracellular
Ca2+ ( Ca2+). At the end of
experiments, cells were again perifused with Ca2+-containing medium
(+Ca2+).
[View Larger Version of this Image (15K GIF file)]
Previously, it has been suggested that VGCC and SOCC participate in
TRH-induced Ca2+ mobilization in lactotrophs (reviewed in
Ref. 12). To test for the involvement of VGCC in mediating the
inhibitory action of ET-1 on secretion, the interaction between the
dihydropyridine Ca2+ channel blockers, nifedipine and
nimodipine, and ET-1 was examined. The inhibitory action of ET-1 on
prolactin release was decreased, but not completely abolished, in the
presence of nifedipine (Fig. 5) and
nimodipine (data not shown). As the magnitude of ET-1-induced inhibition of prolactin release was reduced in the presence of dihydropyridines, it suggests that these VGCC blockers and ET-1 act at
the same point to inhibit secretion. Nifedipine also reduced basal
prolactin release in a manner comparable with that observed in cells
depleted of extracellular Ca2+ (Figs. 4 and 5). The effects
of nifedipine were concentration dependent (Fig. 5, A versus
B). At a higher (100 nM) concentration of nifedipine,
ET-1 was still able to inhibit prolactin release, but the level of
inhibition was only 10-20% of that observed in control cells (Fig.
5B). In TRH-stimulated cells, the plateau phase of
[Ca2+]i response was also reduced by 80-90% in
the presence of 100 nM nifedipine. These observations are
in accord with the hypothesis that L-type voltage-gated channels are
common Ca2+ influx channels involved in the control of
[Ca2+]i and secretion in unstimulated and
agonist-stimulated lactotrophs. Thus, when the Ca2+ influx
through these channels is inhibited by nifedipine, it cannot be further
inhibited by ET-1.
Fig. 5.
Effects of ET-1 on prolactin
(PRL) release in nifedipine-treated perifused pituitary
cells. Shaded bar indicates the duration of ET-1 pulse. The
dotted line illustrates the difference in the levels of
inhibition induced by nifedipine and ET-1. Nifedipine was continuously
present from the moment of application.
[View Larger Version of this Image (35K GIF file)]
To further test this hypothesis, membrane potential was measured in
single free-running lactotrophs. Under the conditions employed in this
study, lactotrophs frequently exhibited spontaneous electrical
activity, which was inhibited by addition of nifedipine (not shown).
Spontaneous electrical activity was abolished in ET-1 as well as in
TRH-stimulated cells (Fig. 6,
A and B). However, the pattern of this inhibition
differed between the two agonists. Thyrotropin-releasing hormone
induced a transient hyperpolarization and cessation of AP firing
followed by an increase in the spiking frequency. In contrast, ET-1
induced a long-lasting hyperpolarization with the cessation of AP
activity, which returned 15-30 min following its removal. The level of
hyperpolarization of lactotrophs by ET-1 was about 80 mV (Fig. 6),
which is close to the equilibrium potential for potassium under our
experimental conditions. This suggests that inhibition of spontaneous
electrical activity is indirect due to activation of a potassium
channel, which hyperpolarizes the cells. Depolarization of cells by
high potassium (Fig. 7) or the addition
of Bay K 8644, an L-type calcium channel agonist (data not shown),
increased [Ca2+]i and prolactin secretion,
further supporting that inhibition of voltage-gated Ca2+
entry is indirect.
Fig. 6.
Changes in membrane potential
(Vm) in ET-1 and TRH-stimulated cells.
A, ET-1 induced an immediate cessation of action potential
firing. Such inhibition was present continuously for at least 30 min
following removal of ET-1. B, TRH-induced transient
inhibition of firing, which was consistently followed by an increase in
the frequency of firing when compared with that before TRH
application.
[View Larger Version of this Image (34K GIF file)]
Fig. 7.
Depolarization-induced activation of
voltage-gated Ca2+ influx in ET-1-stimulated lactotrophs.
A, high potassium-induced increase in
[Ca2+]i in a lactotroph continuously exposed to
100 nM ET-1. B, effects of high
potassium-induced depolarization on prolactin (PRL)
secretion in perifused pituitary cells.
[View Larger Version of this Image (15K GIF file)]
During the ET-1-induced inhibition of electrical activity, TRH was
unable to induce further hyperpolarization or action potential activity. In contrast, addition of ET-1 to cells continuously stimulated with TRH induced an inhibition of sustained extracellular Ca2+-dependent [Ca2+]i
response and prolactin release (Fig. 8,
A and B). This experiment demonstrates that
activation of ET receptors is required for the inhibitory action on
Ca2+ influx. Furthermore, the low amplitude of the spike
[Ca2+]i and prolactin responses to ET-1 in
TRH-stimulated cells (Fig. 8, A and B) as well as
to ionomycin (data not shown) indicates that the ER calcium pool is
almost depleted. The amplitudes of TRH-induced
[Ca2+]i responses also decreased in cells
continuously exposed to 100 nM ET-1 in
Ca2+-deficient (Fig. 8D) as well as
Ca2+-containing medium (data not shown). The amplitudes of
TRH- and ionomycin-induced Ca2+ responses were
progressively reduced in cells stimulated with ET-1, indicating that
the intracellular Ca2+ pool is depleted within 10-15 min
of stimulation (data not shown). Accordingly, application of TRH 20 min
after stimulation with ET-1 did not increase prolactin secretion (Fig.
8C).
Fig. 8.
Interactions between ET-1 and TRH on
[Ca2+]i and prolactin secretion. A
and B, inhibitory effect of ET-1 on TRH-induced prolactin
release from perifused pituitary cells and
[Ca2+]i in three single lactotrophs.
C, the lack of effects of TRH on prolactin release in
ET-1-stimulated cells. D, reduction in the
[Ca2+]i response to TRH following ET-1 treatment.
Dotted tracing represents the TRH response in the absence of
ET-1.
[View Larger Version of this Image (28K GIF file)]
DISCUSSION
The coupling of Ca2+ influx to a Ca2+
mobilization pathway is commonly observed in non-excitable and
excitable cells operated by Ca2+-mobilizing receptors. This
coupling is crucial to the regulation of intracellular Ca2+
homeostasis and Ca2+-controlled cellular functions during
sustained agonist stimulation (18-21). In non-excitable cells,
Ca2+ influx occurs through SOCC in response to
agonist-induced and InsP3-mediated depletion of the ER
calcium pool (22, 23). In general, Ca2+ influx in these
cells is activated independently from the mechanism of depletion of the
ER calcium pool (24, 25). In excitable cells, VGCC are involved in
sustained agonist-induced Ca2+ entry. In these cells, the
pattern of Ca2+ release from intracellular stores
(oscillatory versus non-oscillatory) determines the pattern
of AP firing and associated voltage-gated Ca2+ entry (1). A
family of Ca2+-controlled potassium channels plays a
critical role in the synchronization of Ca2+ mobilization
with the Ca2+ entry process during agonist stimulation (9).
The excitability of these cells, however, does not exclude the
operation of SOCC; in several excitable cells, including lactotrophs,
capacitative calcium entry has also been identified (26).
Pituitary lactotrophs and GH cell lines express several
Ca2+-mobilizing receptors that operate in a manner typical
for this class of receptors, i.e. Ca2+
mobilization is coupled to Ca2+ entry. Within them, TRH
receptors are the best characterized. They are coupled to a
phospholipase C pathway through a Gq/G11 protein (11). Activation of this pathway leads to a non-oscillatory biphasic increase in [Ca2+]i and hormone
secretion, the early phase being dependent on Ca2+
mobilization and the sustained phase on Ca2+ entry (27-29)
(Figs. 3A and 4C). Both voltage-gated and
capacitative Ca2+ entry have been proposed to participate
in TRH-induced Ca2+ influx in these cells. The role of VGCC
and the pattern of TRH-induced electrical activity is well established
(30, 31), whereas the operation of SOCC requires more detailed
investigations (12). The other agonist for these cells, AII, signals
through AT1B receptors that are also coupled to a
phospholipase C pathway (13). Our results indicate that this receptor
operates in a manner comparable with that observed during TRH action.
Furthermore, lactotrophs express V1b vasopressin and
oxytocin receptors, the activation of which are also associated with a
biphasic pattern of Ca2+ signaling and prolactin secretion
(32, 33).
The ET receptor is an additional member of calcium-mobilizing receptors
expressed in lactotrophs as well as in other pituitary cell types (34).
The coupling of this receptor to a phospholipase C pathway in pituitary
cells (4) provides a transient increase in
[Ca2+]i and hormone release (6). In contrast to
TRH and AII action, however, the early stimulatory action of ET-1 is
substituted with a prolonged inhibition of prolactin release. This was
initially observed by Samson et al. (35) and subsequently
confirmed by several other groups (6, 36, 37). In accord with the
binding data (4), it was suggested that inhibition was mediated by ETA receptors (2-4). In addition to the pituitary cells,
inhibition of prolactin release by ET-1 was also observed in human
decidual cells (38), which express ETA receptors as well
(39). Our data demonstrate that uncoupling of Ca2+ influx
from Ca2+ mobilization underlies the bidirectional action
of ETs on prolactin release. Thus, ET-1 exhibits two opposite effects
on Ca2+ signaling, stimulation via Ca2+
mobilization and inhibition of Ca2+ influx pathways.
The lack of effects of TRH and AII to promote Ca2+ influx
in ET-1-stimulated cells and the ability of ET-1 to inhibit
Ca2+ entry in TRH/AII-stimulated cells suggest that these
receptors control the same Ca2+ influx pathway but show the
opposite mode of regulation. Furthermore, the same Ca2+
influx channels control basal [Ca2+]i and
prolactin release. Several lines of evidence presented here and earlier
indicate that Ca2+ influx through L-type
calcium channels rather than SOCC is controlled by these three
calcium-mobilizing receptors. (i) Basal prolactin release is inhibited
by nifedipine and by depletion of extracellular Ca2+.
Spontaneous electrical activity in lactotrophs and GH cells is also
inhibited by nifedipine and requires extracellular Ca2+
(40). (ii) TRH-induced electrical activity, Ca2+ influx,
and prolactin secretion in these cells are nifedipine-sensitive (27,
29, 30). (iii) ET-1 induces a prolonged inhibition of electrical
activity and AP-driven Ca2+ influx through VGCC. The
ability of the L-type Ca2+ channels blocker, nifedipine and
nimodipine, to diminish the inhibitory action of ET-1 on secretion also
suggests that ET-1 acts on VGCC to reduce Ca2+ entry. (iv)
Capacitative Ca2+ entry should be activated automatically
by depletion of the ER calcium pool in cells expressing SOCC. As shown
here, there is a progressive depletion of the ER calcium pool in ET-1-
and TRH-stimulated cells, but this action is accompanied with a reverse
action on Ca2+ influx by these two receptors, inhibition by
ET-1 and stimulation by TRH.
The results also indicate that inhibition of Ca2+ entry
through L-type Ca2+ channels is indirect, possibly due to
activation of potassium channels, leading to a hyperpolarization and
abolition of pacemaker activity. Recently, the role of
large-conductance K+ channels in ET-stimulated lactotrophs
has been suggested (41). These channels are also activated by TRH and
are responsible for a rapid inhibition of electrical activity in
lactotrophs (9). Since these channels are controlled by
[Ca2+]i, however, the inhibition of AP firing is
transient (42) and may explain the early phase in hyperpolarization of these cells. Thus, the sustained inhibition of electrical activity must
be controlled by another yet unidentified potassium channel. Future
experiments should be directed toward identification of this channel,
as well as the mechanism of its activation by ETA receptors, such as direct coupling with G proteins or indirect coupling
through intracellular messenger pathways (43, 44).
In the presence of nifedipine, ET-1 is still able to induce a minor
inhibition of prolactin release. Also, about 10% of basal extracellular Ca2+-dependent hormone secretion
is controlled by Ca2+ influx through nifedipine-insensitive
calcium channels. This influx could be mediated by other VGCC subtypes,
of which the T-type is the best characterized in these cells (45, 46). It is also possible that the residual, nifedipine-insensitive calcium
flux is related to the other family of channels, such as a
tetrodotoxin-insensitive sodium channel identified recently in
lactotrophs and GH3-immortalized cells (47). Both T-type VGCC and the novel sodium channels are capable of providing the pacemaker activity and are functionally connected to the control of
firing of APs. This may provide the explanation for the occurrence of a
nifedipine-insensitive Ca2+ influx in unstimulated cells
and its inhibition and facilitation by ET-1 and TRH, respectively.
Our results also suggest that both ET-1- and TRH-induced
Ca2+ mobilization leads to depletion of the ER
Ca2+ pool but that the rate of depletion does not
immediately mirror the [Ca2+]i profiles. In cells
bathed in Ca2+-deficient medium, application of TRH or
ionomycin during the early phase of decreased
[Ca2+]i resulted in an additional release of
Ca2+. Also, although Ca2+ influx is coupled to
Ca2+ mobilization in TRH-stimulated cells, this pathway
does not protect the cells from a decrease in the ER calcium pool, as
documented by the subsequent application of ET-1 and ionomycin, but is
sufficient to keep the steady-state plateau phase in
[Ca2+]i response. This is consistent with a model
in which the [Ca2+]i in TRH- and ET-1-stimulated
lactotrophs represents the balance between Ca2+
mobilization and Ca2+ influx. In ET-1-stimulated cells,
Ca2+ mobilization is activated, and AP-driven
Ca2+ influx is inhibited, leading to the bidirectional
(spike and sustained inhibitory) change in
[Ca2+]i and a complete depletion in the
intracellular Ca2+ pool. In TRH-stimulated cells, both
pathways are activated, leading to the biphasic (spike and plateau)
change in [Ca2+]i but accompanied by a
progressive decrease in the intracellular Ca2+ pool to a
new steady-state level. However, additional experiments are needed to
define the cellular Ca2+ homeostasis in lactotrophs.
In summary, our results indicate that the signaling through
ETA receptors is essential not only for stimulatory but
also for inhibitory actions of ETs on [Ca2+]i and
prolactin secretion. The latter function of these receptors is mediated
by the uncoupling of Ca2+ mobilization and voltage-gated
Ca2+ entry pathways. Such uncoupling leads to a unique
physiological situation for a Ca2+-mobilizing agonist:
unresponsive cells. The ER calcium pool is depleted due to
Ca2+-mobilizing action of the ET-receptor complex, and,
without a capacitative refilling, other calcium-mobilizing agonists are unable to initiate Ca2+ mobilization. Prolonged
hyperpolarization of lactotrophs also protects these agonists to
activate voltage-gated Ca2+ influx in these cells. Finally,
basal pacemaker activity and hormone secretion are also inhibited. This
makes lactotrophs unresponsive, leading to a sustained
hypoprolactinemia. In this regard, a transient stimulatory action of
ET-1 probably represents only a first step in the development of a
quiescent status of these cells.
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: NICHD/ERRB/UCS, Bldg.
49, Rm. 6A-36, 49 Convent Dr., Bethesda, MD 20892-4510. Tel.:
301-496-2136; Fax: 301-594-7031; E-mail: stankos{at}helix.nih.gov.
1
The abbreviations used are: ET, endothelin; TRH,
thyrotropin-releasing hormone; AII, angiotensin II; ER, endoplasmic
reticulum; SOCC, store-operated calcium channel(s); VGCC, voltage-gated
calcium channel(s); AP, action potential.
REFERENCES
-
Stojilkovic, S. S., and Catt, K. J.
(1992)
Endocr. Rev.
13,
256-280
[Abstract/Free Full Text]
-
Kanyicska, B., and Freeman, M. E.
(1993)
Am. J. Physiol.
265,
E601-E608
[Abstract/Free Full Text]
-
Samson, W. K.
(1992)
Biochem. Biophys. Res. Commun.
187,
590-595
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stojilkovic, S. S., Balla, T., Fukuda, S., Cesnjaj, M., Merelli, F., Krsmanovic, L. Z., and Catt, K. J.
(1992)
Endocrinology
130,
465-474
[Abstract/Free Full Text]
-
Cesnjaj, M., Zheng, L., Catt, K. J., and Stojilkovic, S. S.
(1995)
Mol. Biol. Cell
9,
1037-1047
[Abstract/Free Full Text]
-
Stojilkovic, S. S., Iida, T., Merelli, F., and Catt, K. J.
(1991)
Mol. Pharmacol.
39,
762-770
[Abstract]
-
Samson, W. K., and Skala, K. D.
(1992)
Endocrinology
130,
2964-2970
[Abstract/Free Full Text]
-
Kanyicska, B., Livingstone, J. D., and Freeman, M. E.
(1995)
Endocrinology
136,
990-994
[Abstract]
-
Ozawa, S., and Sand, O.
(1986)
Physiol. Rev.
66,
887-952
[Free Full Text]
-
Stojilkovic, S. S., Izumi, S., and Catt, K. J.
(1988)
J. Biol. Chem.
263,
13054-13061
[Abstract/Free Full Text]
-
Gershengorn, M. C., and Osman, R.
(1996)
Physiol. Rev.
76,
175-191
[Abstract/Free Full Text]
-
Hinkle, P. M., Nelson, E. J., and Ashworth, R.
(1996)
Trends Endocrinol. Metab.
7,
370-374
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kakar, S. S., Sellers, J. C., Devor, D. C., Musgrove, L. C., and Neill, J. D.
(1992)
Biochem. Biophys. Res. Commun.
183,
1090-1096
[CrossRef][Medline]
[Order article via Infotrieve]
-
Tomic, M., Cesnjaj, M., Catt, K. J., and Stojilkovic, S. S.
(1994)
Endocrinology
135,
1762-1771
[Abstract]
-
Stojilkovic, S. S, Kukuljan, M., Iida, T., Rojas, E., and Catt, K. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4081-4085
[Abstract/Free Full Text]
-
Kukuljan, M., Stojilkovic, S. S., Rojas, E., and Catt, K. J.
(1992)
FEBS Lett.
301,
19-22
[CrossRef][Medline]
[Order article via Infotrieve]
-
Barry, P. H.
(1994)
J. Neurosci. Methods
51,
107-116
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rooney, T. A., Sass, E. J., and Thomas, A. P.
(1989)
J. Biol. Chem.
264,
17131-17141
[Abstract/Free Full Text]
-
Loessberg, P. A., Zhao, H., and Muallem, S.
(1991)
J. Biol. Chem.
266,
1363-1366
[Abstract/Free Full Text]
-
Zhao, H., Loessberg, P. A., Sachs, G., and Muallem, S.
(1990)
J. Biol. Chem.
265,
20856-20862
[Abstract/Free Full Text]
-
Stojilkovic, S. S., Iida, T., Merelli, F., Torsello, A., Krsmanovic, L. Z., and Catt, K. J.
(1991)
J. Biol. Chem.
266,
10377-10384
[Abstract/Free Full Text]
-
Putney, J. W., Jr., Bird, G., and St, J.
(1993)
Endocr. Rev.
14,
610-631
[Abstract/Free Full Text]
-
Berridge, M. J.
(1995)
Biochem. J.
312,
1-11
-
Bird, S. J., Rossier, M. F., Hughes, A. R., Shears, S. B., Armstrong, D. L., and Putney, J. W.
(1991)
Nature
352,
162-165
[CrossRef][Medline]
[Order article via Infotrieve]
-
Takemura, H., Hughes, A. R., Thastrup, O., and Putney, J. W., Jr.
(1989)
J. Biol. Chem.
264,
12266-12271
[Abstract/Free Full Text]
-
Villalobos, C., and Garcia-Sancho, J.
(1995)
Pflugers Arch. Eur. J. Physiol.
430,
923-935
[CrossRef][Medline]
[Order article via Infotrieve]
-
Albert, P. R., and Tashjian, A. H., Jr.
(1984)
J. Biol. Chem.
259,
5827-5832
[Abstract/Free Full Text]
-
Nelson, E. J., and Hinkle, P. M.
(1994)
Endocrinology
135,
1084-1092
[Abstract]
-
Winiger, B. P., and Schlegel, W.
(1988)
Biochem. J.
255,
161-167
[Medline]
[Order article via Infotrieve]
-
Li, P., Thaw, C. N., Sempowski, G. D., Gershengorn, M. C., and Hinkle, P. M.
(1992)
Mol. Endocrinol.
6,
1393-1402
[Abstract/Free Full Text]
-
Albert, P. R., and Tashjian, A. H., Jr.
(1984)
J. Biol. Chem.
259,
15350-15363
[Abstract/Free Full Text]
-
Samson, W. K., and Schell, D. A.
(1995)
Adv. Exp. Med. Biol.
395,
355-364
[Medline]
[Order article via Infotrieve]
-
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., and Kawashima, H.
(1994)
J. Biol. Chem.
269,
27088-27092
[Abstract/Free Full Text]
-
Stojilkovic, S. S., and Catt, K. J.
(1992)
Trends Pharmacol. Sci.
13,
385-391
[CrossRef][Medline]
[Order article via Infotrieve]
-
Samson, W. K., Skala, K. D., Alexander, B. D., and Huang, F. L.
(1990)
Biochem. Biophys. Res. Commun.
169,
737-743
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kanyicska, B., Burris, T. P., and Freeman, M. E.
(1991)
Biochem. Biophys. Res. Commun.
174,
338-343
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dymshitz, J., Laudon, M., and Ben-Jonathan, N.
(1992)
Neuroendocrinology
55,
724-729
[Medline]
[Order article via Infotrieve]
-
Chao, H. -S., Myers, S. E., and Handwerger, S.
(1993)
Endocrinology
133,
505-510
[Abstract/Free Full Text]
-
Rutherford, R. A., Wharton, J., McCarthy, A., Gordon, L., Sullivan, M. H., Elder, M. G., and Polak, J. M.
(1993)
Br. J. Pharmacol.
109,
544-552
[Medline]
[Order article via Infotrieve]
-
Schlegel, W., Winiger, B. P., Mollard, P., Vacher, P., Wuarin, F., Zahnd, G. R., Wollheim, C. B., and Dufy, B.
(1987)
Nature
329,
719-721
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kanyicska, B., Freeman, M. E., and Dryer, S. E.
(1997)
Endocrinology
138,
3141-3153
[Abstract/Free Full Text]
-
Ozawa, S., and Kimura, N.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
6017-6020
[Abstract/Free Full Text]
-
Hille, B.
(1994)
Trends Neurosci.
17,
531-536
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wickman, K., and Clapham, D. E.
(1995)
Physiol. Rev.
75,
865-885
[Abstract/Free Full Text]
-
Dubinsky, J. M., and Oxford, G. S.
(1984)
J. Gen. Physiol.
83,
309-339
[Abstract/Free Full Text]
-
Lewis, D. L., Goodman, M. B., St. John, P. A., and Barker, J. L.
(1988)
Endocrinology
123,
611-621
[Abstract/Free Full Text]
-
Sankaranarayanan, S., and Simasko, S. M.
(1996)
Am. J. Physiol.
271,
C1927-C1934
[Abstract/Free Full Text]
Volume 272, Number 45,
Issue of November 7, 1997
pp. 28308-28314
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Hatae, N. Aksentijevich, H. W. Zemkova, K. Kretschmannova, M. Tomic, and S. S. Stojilkovic
Cloning and Functional Identification of Novel Endothelin Receptor Type A Isoforms in Pituitary
Mol. Endocrinol.,
May 1, 2007;
21(5):
1192 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bertram, J. Tabak, N. Toporikova, and M. E. Freeman
Endothelin Action on Pituitary Lactotrophs: One Receptor, Many GTP-Binding Proteins
Sci. Signal.,
January 24, 2006;
2006(319):
pe4 - pe4.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Andric, D. Zivadinovic, A. E. Gonzalez-Iglesias, A. Lachowicz, M. Tomic, and S. S. Stojilkovic
Endothelin-induced, Long Lasting, and Ca2+ Influx-independent Blockade of Intrinsic Secretion in Pituitary Cells by Gz Subunits
J. Biol. Chem.,
July 22, 2005;
280(29):
26896 - 26903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tomic', F. Van Goor, M.-L. He, D. Zivadinovic, and S. S. Stojilkovic
Ca2+-Mobilizing Endothelin-A Receptors Inhibit Voltage-Gated Ca2+ Influx through Gi/o Signaling Pathway in Pituitary Lactotrophs
Mol. Pharmacol.,
June 1, 2002;
61(6):
1329 - 1339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zivadinovic, F. Van Goor, D. Yuan, T.-a. Koshimizu, and S. S. Stojilkovic
Expression of Ca2+-Mobilizing EndothelinA Receptors and Their Role in the Control of Ca2+ Influx and Growth Hormone Secretion in Pituitary Somatotrophs
J. Neurosci.,
September 15, 1999;
19(18):
7721 - 7731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Iglesias, G. Diaz-Torga, V. Lux-Lantos, C. Libertun, and D. Becu-Villalobos
Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab,
September 1, 1999;
277(3):
E455 - E463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mair, M. Frick, A. Meraner, H. Schramek, and P. Dietl
Long-term induction of a unique Cl- current by endothelin-1 in an epithelial cell line from rat lung: evidence for regulation of cytoplasmic calcium
J. Physiol.,
August 15, 1998;
511(1):
55 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|